- Details
- Written by State Department
- Category: News
Washington, DC - The Governments of France, Italy, the United Kingdom, and the United States, recalling their statement of 27 June 2018, welcome the announcement that Libya’s National Oil Corporation is resuming its vital work on behalf of all Libyans. We commend the legitimate National Oil Corporation as it repairs infrastructure, honors its contractual obligations, and, having lifted the state of emergency provisions in eastern Libya, restores oil exports and production critical to Libya’s prosperity. We also appreciate the LNA’s contributions to restore stability in Libya’s oil sector, which is critical to Libya’s national interest.
- Details
- Written by State Department
- Category: News
Washington, DC - From July 24-26, U.S. Secretary of State Michael R. Pompeo will host the first-ever Ministerial to Advance Religious Freedom at the U.S. Department of State in Washington, DC. The Ministerial will convene government officials, representatives of international organizations, religious leaders, rights advocates, and members of civil society organizations from around the world to discuss challenges to religious freedom, identify concrete means to address persecution of and discrimination against religious groups, and promote greater respect for religious freedom for all.
- Details
- Written by FDA Commissioner Scott Gottlieb, M.D.
- Category: News
Washington, DC - Once just a theory, gene therapies are now a therapeutic reality for some patients. These platforms may have the potential to treat and cure some of our most intractable and vexing diseases. The policy framework we construct for how these products should be developed, reviewed by regulators, and reimbursed, will help set the stage for the continued advancement of this new market. Last year, we announced our comprehensive policy framework for regenerative medicine, including a draft guidance that describes the expedited programs, such as the breakthrough therapy designation, and the regenerative medicine advanced therapy (RMAT) designation, that may be available to sponsors of these therapies. Today, we’re unveiling a complementary framework for the development, review and approval of gene therapies.
- Details
- Written by Theresa Eisenman
- Category: News
Washington, DC - The U.S. Food and Drug Administration today is requiring safety labeling changes for a class of antibiotics called fluoroquinolones to strengthen the warnings about the risks of mental health side effects and serious blood sugar disturbances, and make these warnings more consistent across the labeling for all fluoroquinolones taken by mouth or given by injection.
- Details
- Written by State Department
- Category: News
Washington, DC - The United States and Cuba held the fourth Law Enforcement Dialogue in Washington, DC on Tuesday. During the dialogue, the United States and Cuba addressed topics of bilateral interest on national security matters, including fugitives and the return of Cuban nationals with final orders of removal. The delegations also discussed the health attacks against diplomatic personnel at the U.S. Embassy in Havana, including two recent cases. The U.S. delegation reminded the Cubans of their responsibility to protect U.S. diplomats from harm.
- Details
- Written by Patrick Nohe - The SSL Store
- Category: News
Washington, DC - This is why we can’t have nice things…
One of the most common refrains from Certificate Authorities and the digital certificate industry, in general, is ‘never let anything happen to your private key.’ Unfortunately, just saying, “bad things could happen” is a little vague and lacks punch. So here’s a real-world example that can serve as a cautionary tale for everyone.
Subcategories
Page 864 of 1259
- You are here:
-
Home
-
News
-
California News
- News